Temozolomide

Neutropenia and thrombocytopenia: case report

    Reactions Weekly volume 1841, page223(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Baron M, et al. Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma. Blood 135: 1811-1815, No. 20, 14 May 2020. Available from: URL: http://doi.org/10.1182/BLOOD.2019003073

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Temozolomide. Reactions Weekly 1841, 223 (2021). https://doi.org/10.1007/s40278-021-90725-9

    Download citation